Stroke

When Will We Have What We Need to Advise Patients How to Manage Their Carotid Stenosis?: Lessons From SPACE-2. 2023

Hemorrhagic Stroke in Children and Adults with Sickle Cell Anemia: The Post-STOP Cohort.  53:E463-E466. 2022

In Memoriam: Jim Toole, MD: Ahead of His Time..  53:2713-2716. 2022

Repeat Flow Diversion for Cerebral Aneurysms Failing Prior Flow Diversion: Safety and Feasibility From Multicenter Experience.  53:1178-1189. 2022

Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis..  53:956-967. 2022

Health Screening Program to Enhance Enrollment of Women and Minorities in CREST-2.  53:355-361. 2022

Risk Factor Characterization of Ischemic Stroke Subtypes Among West Africans..  53:134-144. 2022

Baseline cognitive impairment in patients with asymptomatic carotid stenosis in the CREST-2 trial.  52:3855-3863. 2021

Racial differences in blood pressure control following stroke the REGARDS study.  52:3944-3952. 2021

Serum zinc levels and incidence of ischemic stroke the reasons for geographic and racial differences in stroke study.  52:3953-3960. 2021

Objectively Measured Physical Activity and Sedentary Time among Adults with and Without Stroke: A National Cohort Study.  52:E729-E732. 2021

Reporting of Results by Sex in Randomized Controlled Trials of Acute Stroke Therapies (2010-2020).  52:E702-E705. 2021

Association of Proportional Recovery after Stroke with Health-Related Quality of Life.  52:2968-2971. 2021

A Primary Care Agenda for Brain Health: A Scientific Statement from the American Heart Association.  52:E295-E308. 2021

Race Differences in High-Grade Carotid Artery Stenosis.  52:2053-2059. 2021

Predictors of poststroke aphasia recovery: A systematic review-informed individual participant data meta-analysis.  52:1778-1787. 2021

Absence of Consistent Sex Differences in Outcomes from Symptomatic Carotid Endarterectomy and Stenting Randomized Trials.  416-423. 2021

Change in Life's Simple 7 Measure of Cardiovascular Health after Incident Stroke: The REGARDS Study.  878-886. 2021

Provider Communication and Telepresence Enhance Veteran Satisfaction With Telestroke Consultations.  52:253-259. 2021

The Utility of Domain-Specific End Points in Acute Stroke Trials.  52:1154-1161. 2021

Approaches to Studying Determinants of Racial-Ethnic Disparities in Stroke and Its Sequelae.  51:3406-3416. 2020

Impact of Multiple Social Determinants of Health on Incident Stroke.  51:2445-2453. 2020

National Institutes of Health StrokeNet during the Time of COVID-19 and beyond.  51:2580-2586. 2020

Abstract TP335: Comparative Impact of Timing From Ictus to Intracerebral Hemorrhage Evacuation on Outcome in MISTIE III, STICH I & II Trials.  51. 2020

Abstract TP444: New Ischemic Lesions on Brain MRI in Patients With Blunt Traumatic Cerebrovascular Injury.  51. 2020

Abstract WMP103: Comparative Impact of Extent of Lobar Intracerebral Hemorrhage Removal on Outcome in the MISTIE III and STICH II Trials.  51. 2020

Depressive Symptoms After Ischemic Stroke: Population-Based Comparisons of Patients and Caregivers With Matched Controls.  51:54-60. 2020

Electrocardiographic ST-T Abnormities Are Associated with Stroke Risk in the REGARDS Study.  1100-1106. 2020

Ischemic Stroke due to Blunt Traumatic Cerebrovascular Injury.  51:353-360. 2020

Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.  2960-2971. 2020

Response by G. Howard and V.J. Howard to Letter Regarding Article, "twenty Years of Progress Toward Understanding the Stroke Belt".  E114-E115. 2020

Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage.  1142-1149. 2020

Twenty years of progress toward understanding the stroke belt.  742-750. 2020

Associations between left ventricular structure, function, and cerebral amyloid the ARIC-PET study.  50:3622-3624. 2019

Associations of perioperative variables with the 30-day risk of stroke or death in carotid endarterectomy for symptomatic carotid stenosis.  50:3439-3448. 2019

Neighborhood Socioeconomic Status and Trajectories of Physical Health-Related Quality of Life Among Stroke Survivors.  50:3191-3197. 2019

Advice from Prior Fellows to Current Fellows on Preparation for Transition to Junior Attending.  50:E250-E252. 2019

Differential Impact of Risk Factors on Stroke Occurrence Among Men Versus Women in West Africa: The SIREN Study.  50:820-827. 2019

Sociodemographic Disparities in Long-Term Mortality Among Stroke Survivors in the United States: The REGARDS Study.  50:805-812. 2019

Abstract 111: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core and Early Presentation.  50. 2019

Abstract 164: Early Infarct Growth Correlates With Both Collateral Status and Clinical Outcomes After Thrombecomy.  50. 2019

Abstract 4: Endovascular Thrombectomy May Be Safe and Effective in Patients With Large Core Lesions on Either Simple CT or Perfusion Images.  50. 2019

Abstract TMP16: IV tPA Does Not Delay Endovascular Thrombectomy and is Associated With Improved Clinical Outcomes.  50. 2019

Abstract TP149: The Effects of Intravenous Thrombolysis on Distal Migration of Clots and Recanalization in Acute Ischemic Strokes Also Treated With Endovascular Therapies.  50. 2019

Abstract WMP9: Does Repeat Images Improve Patient Selection and Clinical Outcomes in Patients Transferred for Endovascular Thrombectomy?.  50. 2019

Abstract WP75: Ischemic Core Volume Modifies the Association Between ASPECT Score and Clinical Outcome.  50. 2019

Safety of Carotid Revascularization in Patients with a History of Coronary Heart Disease.  50:413-418. 2019

Response by Liberman et al to Letter Regarding Article, "Misdiagnosis of Cerebral Vein Thrombosis in the Emergency Department".  49:e280. 2018

Risk factors for poststroke cognitive decline: The REGARDS study (reasons for geographic and racial differences in stroke).  49:987-994. 2018

Abstract TMP90: Prevention of Stroke in Traumatic Cerebrovascular Injury With Aspirin Carries an Increased Risk of Transfusion.  49. 2018

Abstract WP77: Effect of Concurrent Coil Embolization on Delayed Spontaneous Aneurysm Rupture Following Flow Diverter Placement.  49. 2018

Advances in stroke 2017.  49:E174-E199. 2018

Arsenic exposure in relation to ischemic stroke the reasons for geographic and racial differences in stroke study.  49:19-26. 2018

Challenge and yield of enrolling racially and ethnically diverse patient populations in low event rate clinical trials.  49:84-89. 2018

Exome chip analysis identifies low-frequency and rare variants in MRPL38 for white matter hyperintensities on brain magnetic resonance imaging.  49:1812-1819. 2018

Immediate and delayed procedural stroke or death in stenting versus endarterectomy for symptomatic carotid stenosis.  49:2715-2722. 2018

Impact of conventional stroke risk factors on stroke in women an update.  49:536-542. 2018

Misdiagnosis of cerebral vein thrombosis in the emergency department.  49:1504-1506. 2018

Prediction models for clinical outcome after a carotid revascularization procedure an external validation study.  49:1880-1885. 2018

Baseline quality of life and risk of stroke in the ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial).  48:3078-3085. 2017

Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association.  48:e284-e303. 2017

Factors Associated with Time to Site Activation, Randomization, and Enrollment Performance in a Stroke Prevention Trial.  48:2511-2518. 2017

Contributors to the Excess Stroke Mortality in Rural Areas in the United States.  48:1773-1778. 2017

Predicting Domain-Specific Health-Related Quality of Life Using Acute Infarct Volume.  48:1925-1931. 2017

Self-Reported Stroke Risk Stratification.  48:1737-1743. 2017

Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients with Symptomatic Stenosis of the Internal Carotid Artery: Results from 4 Randomized Controlled Trials.  48:1580-1587. 2017

Stroke in Indigenous Africans, African Americans, and European Americans: Interplay of Racial and Geographic Factors.  48:1169-1175. 2017

Use of Platelet Function Testing before Pipeline Embolization Device Placement: A Multicenter Cohort Study.  48:1322-1330. 2017

Ischemic Stroke after Treatment of Intraprocedural Thrombosis during Stent-Assisted Coiling and Flow Diversion.  48:1098-1100. 2017

Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings from Get with the Guidelines-Stroke.  48:686-691. 2017

Stroke Recovery and Rehabilitation Research: Issues, Opportunities, and the National Institutes of Health StrokeNet.  48:813-819. 2017

Response by Gutiérrez et al to letter regarding article, "Hemoglobin concentration and risk of incident stroke in community-living adults".  47:e260. 2016

Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.  47:2373-2379. 2016

Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults.  47:2017-2024. 2016

Where to focus efforts to reduce the black-white disparity in stroke mortality: Incidence versus case fatality?.  47:1893-1898. 2016

Abstract 148: Age Disparities in Acute Stroke Treatment: An Analysis of Six Years of US Hospital Discharges.  47. 2016

Abstract 195: Nosocomial Infections are Associated with Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.  47. 2016

Abstract TMP104: Prevalence of Transcranial Doppler Monitoring in Aneurysmal Subarachnoid Hemorrhage: An Analysis of the Nationwide Inpatient Sample.  47. 2016

Abstract TMP107: Intra-arterial Vasodilators Treat Vasospasm in Aneurysmal Subarachnoid Hemorrhage With Fair Angiographic & Neurological Response, but the Impact on Outcome is Unknown: a Meta-analysis of Observational Studies.  47. 2016

Abstract TP30: Risks and Benefits of Bypassing the Emergency Department for Ischemic Stroke Transferred in for Acute Endovascular Therapy.  47. 2016

Multilingual validation of the questionnaire for verifying stroke-free status in West Africa.  47:167-172. 2016

Trajectories of vasomotor symptoms and carotid intima media thickness in the study of women's health across the nation.  47:12-17. 2016

Summary of evidence on early carotid intervention for recently symptomatic stenosis based on meta-analysis of current risks.  46:3423-3436. 2015

Time from symptoms to carotid endarterectomy or stenting and perioperative risk.  46:3540-3542. 2015

Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.  46:2368-2400. 2015

Temporal Changes in Periprocedural Events in the Carotid Revascularization Endarterectomy Versus Stenting Trial.  46:2183-2189. 2015

Diet and Stroke: Recent Evidence Supporting a Mediterranean-Style Diet and Food in the Primary Prevention of Stroke.  46:2007-2011. 2015

Is Blood Pressure Control for Stroke Prevention the Correct Goal?: The Lost Opportunity of Preventing Hypertension.  46:1595-1600. 2015

Myeloperoxidase Is Increased in Human Cerebral Aneurysms and Increases Formation and Rupture of Cerebral Aneurysms in Mice.  46:1651-1656. 2015

Physical Activity in Primary Stroke Prevention: Just Do It!.  46:1735-1739. 2015

Premature Ventricular Complexes on Screening Electrocardiogram and Risk of Ischemic Stroke.  46:1365-1367. 2015

Response to Letter Regarding Article, "fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults".  46:e124. 2015

Adherence to a Mediterranean diet and prediction of incident stroke.  46:780-785. 2015

Effect of patching on reducing restenosis in the Carotid Revascularization Endarterectomy versus Stenting Trial.  46:757-761. 2015

Fibroblast growth factor 23 and risk of incident stroke in community-living adults.  46:322-328. 2015

Abstract 68: Palliative Care Is Underutilized in Patients with Severe Intracerebral Hemorrhage.  46. 2015

Abstract T MP91: A Simple Systemic Inflammatory Response Syndrome Prediction Score for Patients with Intracerebral Hemorrhage.  46. 2015

Abstract T P325: The Role Of A History Of Coronary Artery Disease, The Need For Transfusion And Outcomes In Patients With Intracerebral Hemorrhage.  46. 2015

Abstract T P326: The Utility of Charlson Comorbidity Index in Predicting Short-term Outcomes in Patients with Primary Intracerebral Hemorrhage.  46. 2015

Abstract T P404: The Influence Of Systemic Inflammatory Response Syndrome, In The Absence Of Infection, On The Relationship Between Intracerebral Hemorrhage Score And Outcomes.  46. 2015

Abstract W P270: Quality of In-Hospital Stroke Care in Veterans Affairs Hospitals.  46. 2015

Abstract W P309: Serum Albumin Predicts Outcome In Primary Intracerebral Hemorrhage.  46. 2015

Abstract W P324: The Influence Of Low Density Lipoprotein On Intracerebral Hemorrhage Volume.  46. 2015

Abstract W P328: Elevated Systolic Blood Pressure on Arrival is Not Associated with Higher Early Mortality in Intracerebral Hemorrhage Patients.  46. 2015

Abstract W P329: Systemic Inflammatory Response Syndrome during Hospitalization for Intracerebral Hemorrhage Drives Poor Functional Outcome at Discharge.  46. 2015

Abstract W P332: Ratio of Blood Urea Nitrogen to Serum Creatinine Predicts Primary Intracerebral Hemorrhage Volume.  46. 2015

Abstract W P333: Seizure as the Presenting Symptom of ICH Patient Characteristics and EEG Utilization.  46. 2015

Abstract W P334: Admission Blood Pressure Predicts The Number Of Medications Upon Discharge In Patients With Primary Intracerebral Hemorrhage.  46. 2015

Abstract W P335: The Impact of Electrolyte Abnormalities in Primary Intracerebral Hemorrhage.  46. 2015

Mediators of the age effect in the carotid revascularization endarterectomy versus stenting trial (CREST).  46:2868-2873. 2015

Rapid assessment and treatment of transient ischemic attacks and minor stroke in Canadian emergency departments: Time for a paradigm shift.  46:2987-2990. 2015

Common caregiver issues following a stroke 2014

Translational neurorehabilitation research in the third world: what barriers to trial participation can teach us..  45:1495-1497. 2014

Abstract T P52: Technique for Measurement of Traumatic Aneurysms of the Cervical Internal Carotid Artery and Assessment of Reproducibility.  45. 2014

Abstract W MP6: Pre-treatment Neuroimaging Is Critical to Identify Acute Stroke Patients With Large Infarcts Unlikely to Respond to Endovascular Therapy.  45. 2014

Abstract W P53: Extracranial Traumatic Aneurysms Due to Blunt Cerebrovascular Injury.  45. 2014

Advances in stroke population studies 2013.  45:368-370. 2014

Assessing the performance of the framingham stroke risk score in the reasons for geographic and racial differences in stroke cohort.  45:1716-1720. 2014

Common caregiver issues and nursing interventions after a stroke.  45. 2014

Complication rates and center enrollment volume in the carotid revascularization endarterectomy versus stenting trial.  45:3320-3324. 2014

Factors influencing the decline in stroke mortality a statement from the american heart association/american stroke association.  45:315-353. 2014

Guidelines for the prevention of stroke in women: A statement for healthcare professionals from the American heart association/American stroke association.  45:1545-1588. 2014

N-terminal pro-B-type natriuretic peptide and stroke risk: The reasons for geographic and racial differences in stroke cohort.  45:1646-1650. 2014

Picking the good apples: Statistics versus good judgment in choosing stent operators for a multicenter clinical trial.  45:3325-3329. 2014

Racial differences in the association of insulin resistance with stroke risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  45:2257-2262. 2014

Risk adjustment of ischemic stroke outcomes for comparing hospital performance a statement for healthcare professionals from the american heart association/american stroke association.  45:918-944. 2014

Dietary patterns are associated with incident stroke and contribute to excess risk of stroke in black americans.  44:3305-3311. 2013

Ancel keys lecture adventures (and misadventures) in understanding (and reducing) disparities in stroke mortality.  44:3254-3259. 2013

Physical activity frequency and risk of incident stroke in a National US study of blacks and whites.  44:2519-2524. 2013

Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome.  44:2321-2323. 2013

Disparities in evaluation at certified primary stroke centers: Reasons for geographic and racial differences in stroke.  44:1930-1935. 2013

Life's simple 7 and risk of incident stroke: The reasons for geographic and racial differences in stroke study.  44:1909-1914. 2013

Method for enhancing real-world use of a more affected arm in chronic stroke: Transfer package of constraint-induced movement therapy.  44:1383-1388. 2013

Risk factors for intracerebral hemorrhage: The reasons for geographic and racial differences in stroke (REGARDS) study.  44:1282-1287. 2013

Abstract WMP78: Investigating the Utility of Previously Developed Prediction Scores in AIS patients in the Stroke Belt.  44. 2013

Real-time validation of transcranial doppler criteria in assessing recanalization during intra-arterial procedures for acute ischemic stroke an international, multicenter study.  44:394-400. 2013

Forecasting the future of stroke in the united states: A policy statement from the American heart association and American stroke association.  44:2361-2375. 2013

Reasons underlying racial differences in stroke incidence and mortality.  44. 2013

Self-report of stroke, transient ischemic attack, or stroke symptoms and risk of future stroke in the reasons for geographic and racial differences in stroke (REGARDS) study.  44:55-60. 2013

The current state and future of stroke: Introduction.  44. 2013

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS).  43:2682-2688. 2012

How do we know if we are making progress in reducing the public health burden of stroke?.  43:2033-2034. 2012

Response to letter regarding article entitled "a simple, assumption-free, and clinically interpretable approach for analysis of modified rankin outcomes".  43. 2012

Association between family risk of stroke and myocardial infarction with prevalent risk factors and coexisting diseases.  43:974-979. 2012

Statistical analysis of the primary outcome in acute stroke trials.  43:1171-1178. 2012

A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes.  43:664-669. 2012

Abstract 121: Symptomatic Intracranial Atherosclerotic Disease in Acute Cerebral Ischemia: Frequency, Clinical Course and Short-Term Outcome in a Tertiary Care Hospital in the Southeastern United States.  43. 2012

Abstract 1: Did Carotid Stenting and Endarterectomy Outcomes Change Over Time in the Carotid Revascularization Endarterectomy versus Stenting Trial?.  43. 2012

Advances in stroke: Population studies.  43:305-307. 2012

Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke.  43:453-457. 2012

Age and outcomes after carotid stenting and endarterectomy: The Carotid Revascularization Endarterectomy Versus Stenting Trial.  42:3484-3490. 2011

Traditional risk factors as the underlying cause of racial disparities in stroke: Lessons from the half-full (empty?) glass.  42:3369-3375. 2011

Velocity criteria for intracranial stenosis revisited: An international multicenter study of transcranial Doppler and digital subtraction angiography.  42:3429-3434. 2011

Self-reported stroke symptoms without a prior diagnosis of stroke or transient ischemic attack: A powerful new risk factor for stroke.  42:3122-3126. 2011

Self-reported atrial fibrillation and risk of stroke in the reasons for geographic and racial differences in stroke (REGARDS) study.  42:2950-2953. 2011

Simplified modified rankin scale questionnaire: Reproducibility over the telephone and validation with quality of life.  42:2276-2279. 2011

Racial-ethnic disparities in stroke care: The American experience: A statement for healthcare professionals from the American Heart Association/American Stroke Association.  42:2091-2116. 2011

Wisdom and determination in the ongoing pursuit of the ever-elusive neuroprotective agent.  42:1505-1506. 2011

Safety and tolerability of early noninvasive ventilatory correction using bilevel positive airway pressure in acute ischemic stroke.  42:1030-1034. 2011

Age and Outcomes following Stenting compared to Endarterectomy: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).  42:E46-E46. 2011

Albuminuria, Kidney Function and Risk of Stroke in the REGARDS Cohort.  42:E192-E193. 2011

Could Racial Differences In Susceptibility To Elevated Blood Pressures Contribute To The Excess Stroke Mortality In Blacks: The Reasons For Geographic And Racial Differences In Stroke (REGARDS) Study?.  42:E49-E49. 2011

Do Demographic Disparities in Neuroimaging Utilization Exist in Stroke? The REGARDS Experience.  42:E130-E130. 2011

Effect of Diabetes (DM) on Ischemic Stroke Incidence and Case Fatality.  42:E116-E117. 2011

Effects of exercise on quality of life in stroke survivors: A meta-analysis.  42:832-837. 2011

Geographic Disparities in Elevated Blood Pressures, but Not Resistant Hypertension in Southeast: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.  42:E49-E49. 2011

Health-Related Quality of Life after Carotid Stenting versus Carotid Endarterectomy: Results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).  42:E78-E78. 2011

Lower Executive Function Increases Risk For Incident Stroke in the National REGARDS Cohort.  42:E55-E56. 2011

Predictors of Short Term Clinical Outcome Following Stroke in the Young: Data from a Tertiary Care Center in the US "Stroke Belt".  42:E274-E274. 2011

Prevalence and Significance of Unrecognized Myocardial Infarctions with Stroke Risk: The REGARDS Study.  42:E102-E102. 2011

Race and gender differences in 1-year outcomes for community-dwelling stroke survivors with family caregivers.  42:626-631. 2011

Risk Of Stroke Following Self-report Of Stroke, Tia Or Stroke Symptoms In The Regards Study.  42:E195-E195. 2011

Safety of Carotid Stenting and Endarterectomy in Symptomatic and Asymptomatic Patients: Results from the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST).  42:E45-E45. 2011

Self-Reported Stroke Symptoms Without a Prior Diagnosis of Stroke or TIA: A Powerful New Risk Factor for Stroke.  42:E103-E104. 2011

Stroke Risk in Persons with Heart Failure: The REGARDS Study.  42:E271-E271. 2011

Subclinical Stroke Symptoms and Diabetes in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.  42:E273-E274. 2011

Guidelines for the primary prevention of stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association.  42:517-584. 2011

Pumps, aqueducts, and drought management: Vascular physiology in vascular cognitive impairment.  42:221-226. 2011

Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).  42:675-680. 2011

The EXCITE stroke trial: Comparing early and delayed constraint-induced movement therapy.  41:2309-2315. 2010

Improvement in aphasia scores after stroke is well predicted by initial severity.  41:1485-1488. 2010

Improving modified rankin scale assessment with a simplified questionnaire.  41:1048-1050. 2010

Diagnostic criteria and yield of real-time transcranial doppler monitoring of intra-arterial reperfusion procedures.  41:695-699. 2010

Racial Disparities in Awareness and Treatment of Atrial Fibrillation: The Reasons for Geographic and Racial Differences in Stroke Study.  41:E245-E245. 2010

Racial disparities in awareness and treatment of atrial fibrillation: The REasons for geographic and racial differences in stroke (REGARDS) study.  41:581-587. 2010

Stroke Incidence as the Major Contributor to Racial and Regional Disparities in Stroke Mortality: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.  41:E244-E245. 2010

Traditional Risk Factors Play a Minor Role in the Excess Stroke Incidence of African Americans: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.  41:E225-E225. 2010

Caregiving strain and estimated risk for stroke and coronary heart disease among spouse caregivers: Differential effects by race and sex.  41:331-336. 2010

Ancrod in acute ischemic stroke: Results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program.  40:3796-3803. 2009

Blood pressure and stroke in heart failure in the reasons for geographic and racial differences in stroke (regards) study.  40:3706-3710. 2009

Recommendations for imaging of acute ischemic stroke: A scientific statement from the american heart association.  40:3646-3678. 2009

Prevalence and risk factors associated with reversed robin hood syndrome in acute ischemic stroke.  40:2738-2742. 2009

Improvement after constraint-induced movement therapy is independent of infarct location in chronic stroke patients.  40:2468-2472. 2009

Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage.  40:2362-2367. 2009

Elderly Women Have Lower Rates of Stroke, Cardiovascular Events, and Mortality After Hospitalization for Transient Ischemic Attack.  40:2116-2122. 2009

Problems and benefits reported by Stroke family caregivers: Results from a prospective epidemiological study.  40:2129-2133. 2009

Regional implementation of the stroke systems of care model: Recommendations of the northeast cerebrovascular consortium.  40:1793-1802. 2009

Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men results from the carotid revascularization endarterectomy versus stenting trial (CREST) lead-in phase.  40:1140-1147. 2009

Feasibility of Epidemiology-Driven Multi-Modal Community Stroke Prevention Screening in High Risk African American (AA) Communities.  40:E183-E183. 2009

Framingham Stroke Risk by Duration and Age at Exposure to the Stroke Belt..  40:E189-E189. 2009

Genomics of human intracranial aneurysm wall.  40:1252-1261. 2009

Stroke Symptoms Without Stroke Or Tia Diagnosis Are Associated With Higher Mortality.  40:E187-E187. 2009

High-risk populations introduction.  40. 2009

Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: The REasons for geographic and racial differences in stroke study.  39:1675-1680. 2008

Genome screen to detect linkage to intracranial aneurysm susceptibility genes: The familial intracranial aneurysm (FIA) study.  39:1434-1440. 2008

Advances in population studies 2007.  39:283-285. 2008

Association between increased diastolic blood pressure levels and cognitive impairment: the reasons for geographic and racial differences in stroke (REGARDS) study..  39:544-544. 2008

Closure of the lead-in phase of CREST (carotid revascularization endarterectomy vs. stenting trial): 30-day and one year analyses.  39:557-557. 2008

Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke?.  39:556-556. 2008

Inadequate awareness and control of vascular risk factors in stroke patients: The REasons for geographic and racial differences in stroke (REGARDS) study.  39:630-630. 2008

Stroke risk factors are predictive of cognitive decline in the absence of clinically diagnosed incident stroke.  39:559-559. 2008

Remodeling the brain: plastic structural brain changes produced by different motor therapies after stroke..  39:1520-1525. 2008

The importance of epidemiological studies should not be downplayed.  39:1-2. 2008

Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with a decrease in indices of mental and physical functioning.  38:2446-2452. 2007

From sea to shining sea: What is it about where you live and your stroke risk?.  38:2210-2212. 2007

Reduced medication access: A marker for vulnerability in US stroke survivors.  38:1557-1564. 2007

Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  38:1143-1147. 2007

Factors associated with care-seeking behavior in response to stroke symptoms: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  38:528-528. 2007

Nonconventional clinical trial designs: Approaches to provide more precise estimates of treatment effects with a smaller sample size, but at a cost.  38:804-808. 2007

Periprocedural hemorrhagic and hemodynamic events are associated with increased risk in carotid artery stenting: The carotid revascularization endarterectomy vs stenting trial (CREST).  38:483-483. 2007

Racial and geographic differences in prevalence, awareness, treatment, and control of dyslipidemia: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  38:533-533. 2007

Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes.  38:245-248. 2007

Reduced medication access: A marker for vulnerability in US stroke survivors.  38:479-479. 2007

Stroke symptoms in individuals reporting no prior stroke or TIA are associated with a decrease in indices of mental and physical functioning.  38:482-482. 2007

The association between family risk of stroke and family risk of heart attack with prevalent risk factors and coexisting diseases: Challenges for the understanding of the genetics of stroke and heart disease.  38:528-528. 2007

Primary prevention of ischemic stroke. A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council.  37:1583-1633. 2006

Racial and geographic differences in awareness, treatment, and control of hypertension: The REasons for geographic and racial differences in stroke study.  37:1171-1178. 2006

A placebo-controlled trial of constraint-induced movement therapy for upper extremity after stroke.  37:1045-1049. 2006

1-year restenosis after carotid stenting in the lead-in phase of the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST).  37:620-620. 2006

Impaired cognitive screening status is associated with stroke symptom reports and modifiable health-related behaviors after controlling for age, education, ethnicity, and regional variation in stroke risk.  37:673-673. 2006

Socioeconomic status and control of stroke risk factors: The reasons for geographic and racial differences in stroke study.  37:668-668. 2006

Reliability and validity of the upper-extremity motor activity log-14 for measuring real-world arm use.  36:2493-2496. 2005

Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens.  36:1622-1623. 2005

Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens.  36:1622-1623. 2005

Recommendations for comprehensive stroke centers: A consensus statement from the brain attack coalition.  36:1597-1616. 2005

AutoCITE: Automated delivery of CI therapy with reduced effort by therapists.  36:1301-1304. 2005

Regional differences in the increased stroke mortality of African Americans: The remarkable stroke burden of being a Southern African American.  36:427-427. 2005

Targets for vascular protection after acute ischemic stroke.  35:2220-2225. 2004

Effect of untreated hypertension on hemorrhagic stroke.  35:1703-1708. 2004

Ischemic stroke subtypes: A population-based study of incidence rates among blacks and whites.  35:1552-1556. 2004

Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: A case-control study.  35:1360-1363. 2004

Stroke in a Biracial Population: The Excess Burden of Stroke among Blacks.  35:426-431. 2004

Does the stroke risk of stenting increase at older ages? Thirty-day stroke-death rates in the CREST lead-in phase.  35:258-258. 2004

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study..  35. 2004

Gender and periprocedural stroke and death following carotid artery stenting: Results from the CREST lead-in phase.  35:253-253. 2004

Timing of cerebrovascular events in CREST lead-in patients.  35:254-254. 2004

Identifying Risk Factors for Perioperative Outcomes After Carotid Endarterectomy: The Story Continues.  34:2573-2575. 2003

Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.  34:2323-2330. 2003

Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease.  34:945-949. 2003

Midazolam challenge reinduces neurological deficits after transient ischemic attack.  34:794-796. 2003

Racial differences in thoracic aorta atherosclerosis among ischemic stroke patients.  34:408-412. 2003

Re: Telephone intervention with family caregivers of stroke survivors after rehabilitation [6] (multiple letters).  34:7-8. 2003

Telephone intervention with family caregivers of stroke survivors after rehabilitation.  33:2060-2065. 2002

Genetic and environmental risk factors for intracerebral hemorrhage: Preliminary results of a population-based study.  33:1190-1195. 2002

Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood institute Family Heart Study.  33:1357-1361. 2002

Hypoxic-ischemic injury induces macrophage inflammatory protein-1α expression in immature rat brain.  33:795-801. 2002

Changes in plasma homocyst(e)ine in the acute phase after stroke.  33:473-478. 2002

Reemergence of stroke deficits with midazolam challenge.  33:283-285. 2002

Geographic differences in the magnitude of the African American excess risk of stroke death.  33:391-391. 2002

Practice makes perfect.  33:1856. 2002

Practice makes perfect..  33:1856. 2002

Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS) [5] (multiple letters).  32:1447-1448. 2001

Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS) - Response.  32:1448-1448. 2001

Constraint-induced therapy of chronic aphasia after stroke.  32:1621-1626. 2001

Decline in US stroke mortality an analysis of temporal patterns by sex, race, and geographic region.  32:2213-2218. 2001

Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.  32:1091-1096. 2001

Intrathecal baclofen for spastic hypertonia from stroke.  32:2099-2107. 2001

Parallel hypothesis testing for science and industry in a large randomized clinical trial.  32:328-328. 2001

Primary prevention of ischemic stroke: A statement for healthcare professionals from the stroke council of the American Heart Association.  32:280-299. 2001

Stability of plasma homocyst(e)ine in acute stroke patients (SHASP).  32:361-361. 2001

The decline in stroke mortality: an analysis of temporal patterns by sex, race and geographic region.  32:320-320. 2001

Anticoagulant patient information material is written at high readability levels.  31:2966-2970. 2000

Depression and other determinants of values placed on current health state by stroke patients: Evidence from the VA acute stroke (VASt) study.  31:2603-2609. 2000

Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS).  31:2330-2334. 2000

Evolution of cortical activation during recovery from corticospinal tract infarction.  31:656-661. 2000

Objective measurement of functional upper-extremity movement using accelerometer recordings transformed with a threshold filter.  31:662-667. 2000

Racial variation in initial stroke severity.  31:563-567. 2000

Treatment-induced cortical reorganization after stroke in humans.  31:1210-1216. 2000

Effects of constraint-induced movement therapy on patients with chronic motor deficits after stroke: A replication.  30:586-592. 1999

Geographic variations in major stroke risk factors.  30:255-255. 1999

Stroke incidence and survival among middle-aged adults: 9-Year follow- up of the Atherosclerosis Risk in Communities (ARIC) cohort.  30:736-743. 1999

The effect of contralateral occlusion on peri-operative and late stroke rates in the asymptomatic carotid atherosclerosis study (ACAS).  30:242-242. 1999

Carotid stenting and angioplasty: a statement for healthcare professionals from the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology and Prevention, and Clinical Cardiology, American Heart Association..  29:336-338. 1998

Cigarette smoking and other risk factors for silent cerebral infarction in the general population.  29:913-917. 1998

Increased workload enhances force output during pedaling exercise in persons with poststroke hemiplegia.  29:598-606. 1998

Recurrent carotid stenosis: Results of the asymptomatic carotid atherosclerosis study.  29:2018-2025. 1998

Does the Association of Risk Factors and Atherosclerosis Change With Age?.  28:1693-1701. 1997

Cigarette smoking and silent cerebral infarctions in the general population.  28:92-92. 1997

Consistency of Doppler parameters in predicting arteriographically confirmed carotid stenosis.  28:343-347. 1997

Does the association of risk factors and atherosclerosis change with age? An analysis of the combined ARIC and CHS cohorts.  28:1693-1701. 1997

Evaluation of social status as a contributing factor to the stroke belt region of the United States.  28:936-940. 1997

Familial history of stroke and stroke risk: The Family Heart Study.  28:1908-1912. 1997

Family history of stroke and MRI abnormalities: The ARIC study.  28:175-175. 1997

Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction: The TIMI-II pilot and randomized clinical trial combined experience.  28:1107-1114. 1997

Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects: The insulin resistance atheroselerosis study (IRAS).  28:1710-1716. 1997

An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance). A multicenter experience. Asymptomatic Carotid Atherosclerosis Study Investigators..  27:1951-1957. 1996

Successful use of dissimilar Doppler devices as a screening tool for hemodynamically significant stenosis in ACAS.  27:790-790. 1996

A new approach to assess geographical patterns in stroke mortality.  27:1-1. 1996

An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance): A multicenter experience.  27:1951-1957. 1996

Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening.  27:1755-1759. 1996

Ethnic differences in carotid wall thickness: The Insulin Resistance Atherosclerosis Study.  27:1744-1749. 1996

COMMON CAROTID VOLUME FLOW-RATES CORRELATE TO IPSILATERAL AND CONTRALATERAL INTERNAL CAROTID-ARTERY STENOSIS.  26:727-727. 1995

Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: The atherosclerosis risk in communities (aric) study.  26:386-391. 1995

Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats.  26:1093-1100. 1995

Is the stroke belt disappearing?: An analysis of racial, temporal, and age effects.  26:1153-1158. 1995

Response: Steal and cerebral arteriovenous malformations.  26:2371-2372. 1995

Role of social class in excess black stroke mortality.  26:1759-1763. 1995

Steal and cerebral arteriovenous malformations.  26:2371. 1995

The end of the stroke belt?: It may be too early to declare victory!.  26:1150-1152. 1995

‘steal’ is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations.  26:1215-1220. 1995

Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Atherosclerosis Risk in Communities..  25:1581-1587. 1994

Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study..  25:1122-1129. 1994

A prospective reevaluation of transient ischemic attacks as a risk factor for death and fatal or nonfatal cardiovascular events.  25:342-345. 1994

Cerebral hyperemia in melas.  25:1873-1876. 1994

ETHNIC-DIFFERENCES IN CAROTID-ARTERY INTIMA-MEDIA THICKNESS AMONG NONDIABETICS - BLACKS, HISPANIC WHITES, AND NON-HISPANIC WHITES.  25:251-251. 1994

Ethnic differences in stroke mortality between non-hispanic whites, hispanic whites, and blacks the national longitudinal mortality study.  25:2120-2125. 1994

Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-Mode ultrasound.  25:1581-1587. 1994

Spatial distribution of carotid intimal-medial.  25:1812-1819. 1994

Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound.  24:1297-1304. 1993

Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats.  24:2016-2021. 1993

Familial aggregation of stroke the framingham study.  24:1366-1371. 1993

Nearing the finish line? The asymptomatic Carotid Atherosclerosis Study..  23:1054-1055. 1992

Comparison of multicenter study designs for investigation of carotid endarterectomy efficacy.  23:583-593. 1992

Nearing the finish line?.  23:1054-1055. 1992

Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects.  23:823-828. 1992

Risks and benefits of shunting in carotid endarterectomy.  23:1583-1587. 1992

Selection process for surgeons in the Asymptomatic Carotid Atherosclerosis Study..  22:1353-1357. 1991

A MULTICENTER VALIDATION OF DOPPLER ULTRASOUND VERSUS ANGIOGRAM - THE ACAS EXPERIENCE.  22:147-147. 1991

Cerebral infarction verified by cranial computed tomography and prognosis for survival following transient ischemic attack.  22:431-436. 1991

OBSERVED HETEROGENEITY IN THE DECLINE OF STROKE MORTALITY IN THE UNITED-STATES FROM 1968 TO 1985.  22:126-126. 1991

Reevaluation of transient ischemic attacks as a risk factor for early mortality.  22:582-585. 1991

Correlation of carotid bruits and carotid atherosclerosis..  21:678-679. 1990

A REEVALUATION OF TIA AS A RISK FACTOR FOR EARLY MORTALITY.  21:168-168. 1990

Community hospital-based stroke programs in north carolina, oregon, and new york: IV. Stroke diagnosis and its relation to demographics, risk factors, and clinical status after stroke.  21:867-873. 1990

Correlation of carotid bruits and carotid atherosclerosis the following is in reply: To the editor.  21:678-679. 1990

Effect of emitted power on waveform intensity in transcranial doppler.  21:1573-1578. 1990

Lacunar infarction due to middle cerebral artery stenosis.  21:1759. 1990

Blood velocity in the middle cerebral artery and regional cerebral blood flow during carotid endarterectomy.  20:53-58. 1989

Changes in survival following stroke in five north carolina counties observed during two different periods.  20:345-350. 1989

Correlation of carotid bruits and carotid atherosclerosis detected by b-mode real-time ultrasonography.  20:1331-1335. 1989

Original contributions study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis.  20:844-849. 1989

Prognosis of acute hemiplegia estimated by transcranial doppler ultrasonography.  19:648-649. 1988

Comparisons of oxygen metabolism and tissue po2in cortex and hippocampus of gerbil brain.  18:616-622. 1987

Declining morbidity and mortality of carotid endarterectomy: The wake forest university medical center experience.  18:823-829. 1987

Factors influencing the survival of 451 transient ischemic attack patients.  18:552-557. 1987

Risk factors for extracranial carotid artery atherosclerosis.  18:990-996. 1987

Community hospital-based stroke programs: North Carolina, Oregon, and New York: I. Goals, objectives, and data collection procedures.  17:276-284. 1986

Community hospital-based stroke programs: North Carolina, Oregon, and New York: II. Description of study population.  17:285-293. 1986

Community hospital-based stroke programs: North Carolina, Oregon, and New York: III. Factors influencing survival after stroke: Proportional hazards analysis of 4219 patients.  17:294-299. 1986

Evaluation of the north carolina stroke care program.  17:382-386. 1986

Progressive lacunar infarction with demonstrated patency of the middle cerebral artery.  17:1028-1030. 1986

The sex difference in manifestations of carotid bifurcation disease.  17:877-881. 1986

Transcranial doppler and rcbf compared in carotid endarterectomy.  17:1206-1208. 1986

Brainstem auditory evoked responses in brainstem infarction.  16:701-705. 1985

Comparison of external lung monitoring with end-tidal air detection using the ¹³³xenon inhalation method.  16:964-968. 1985

Measurement of activated rcbf by the 133xe inhalation technique: A comparison of total versus partial curve analysis.  16:274-282. 1985

Differential regional vulnerability in transient focal cerebral ischemia.  13:339-346. 1982

Mathematical simulation of cerebral blood flow in focal ischemia.  13:693-700. 1982

The hemodynamic effect of sta-mca bypass.  13:163-167. 1982

Sensitivity of rCBF to focal lesions.  12:631-635. 1981

Amelioration of cerebral ischemia by prior treatment of hypertension.  11:235-240. 1980

Angiographic appearance of carotid occlusion in acute stroke.  11:485-487. 1980

Comparison of doppler ultrasonography with arteriography of the carotid artery bifurcation.  11:402-404. 1980

Differing CO2 reactivity of absolute and relative CBF in healthy man. A study with the 133-Xe inhalation method.  10:482. 1979

Effects of barbiturates on intracranial pressure and amount of mannitol required to control the intracranial pressure.  10:486-487. 1979

¹³³xenon inhalation method: Significance of indicator maldistribution for distinguishing brain areas with impaired perfusion: An index for total flow.  9:57-66. 1978

Effect of aminophylline on cerebral infarction in the Mongolian Gerbil.  9:477-479. 1978

Xenon-133 inhalation method for regional cerebral blood flow measurements: Normal values and test-retest results.  9:396-399. 1978

¹³³Xenon inhalation method: Analysis of reproducibility: Some of its physiological implications.  8:92-102. 1977

Use of hydrogen for measurement of regional cerebral blood flow: Problem of intercompartmental diffusion.  8:351-357. 1977

Comparison of local blood flow and oxygen availability at the same locus in the ischemic gerbil brain.  7:274-278. 1976

Comparison of vascular reactivity in spinal cord and brain.  7:560-563. 1976

Effects of ischemia on the mg⁺⁺ requiring adenosine triphosphatase associated with neuronal synaptic vesicles in gerbil brain.  7:36-40. 1976

Regional cerebral blood flow by¹³³xenon inhalation preliminary evaluation of an initial slope index in patients with unstable flow compartments.  6:142-148. 1975

Oxygen Cycles and Metabolic Autoregulation.  5:219-226. 1974

Regional cerebral blood flow in acute stroke: Preliminary experience with the ¹³³Xenon inhalation method.  5:8-12. 1974

Occlusion of all four extracranial vessels with minimal clinica symptomatology. Case report.  3:462-466. 1972

The course of experimental cerebral infarction-the development of increased intracranial pressure.  3:268-278. 1972

Validation of jugular venous flow as an index of total cerebral blood flow.  3:300-321. 1972

An improved thermal dilution method for measuring jugular venous flow.  2:128-137. 1971

Physiological modification of immediate ischemia due to experimental middle cerebral occlusion-its relevance to cerebral infarction.  2:239-246. 1971

Bilateral jugular venous blood flow by thermal dilution.  1:348-355. 1970